Yamaguchi M - Search Results

1

High-dose cytarabine plus gemtuzumab ozogamicin as consolidation therapy in patients with favorable- or intermediate-risk acute myeloid leukemia.

Oya S, Ozawa H, Morishige S, Maehiro Y, Umeda M, Takaki Y, Fukuyama T, Yamasaki Y, Nakamura T, Yamaguchi M, Aoyama K, Mouri F, Nagafuji K. Oya S, et al. Among authors: yamaguchi m. Int J Hematol. 2024 Sep;120(3):297-304. doi: 10.1007/s12185-024-03814-z. Epub 2024 Jul 4. Int J Hematol. 2024. PMID: 38963637

2

Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation.

Morishige S, Nishi M, Saruta H, Arakawa F, Yamasaki Y, Oya S, Nakamura T, Seki R, Yamaguchi M, Aoyama K, Mouri F, Osaki K, Ohshima K, Nagafuji K. Morishige S, et al. Among authors: yamaguchi m. Int J Hematol. 2019 Oct;110(4):506-511. doi: 10.1007/s12185-019-02675-1. Epub 2019 May 31. Int J Hematol. 2019. PMID: 31152415

3

[Allogeneic hematopoietic stem cell transplantations for relapsed and refractory acute lymphoblastic leukemia following inotuzumab ozogamicin treatment].

Morishige S, Yamasaki Y, Oya S, Nakamura T, Yamaguchi M, Aoyama K, Mouri F, Mizushima Y, Nakashima O, Nagafuji K. Morishige S, et al. Among authors: yamaguchi m. Rinsho Ketsueki. 2022;63(4):271-276. doi: 10.11406/rinketsu.63.271. Rinsho Ketsueki. 2022. PMID: 35491216 Japanese.

4

[FLT3-ITD and NPM1 mutation positive acute myeloid leukemia with cuplike blasts mimicking acute promyelocytic leukemia].

Aoyama K, Yamasaki Y, Mouri F, Maehiro Y, Takaki Y, Oya S, Nakamura T, Morishige S, Yamaguchi M, Nagafuji K. Aoyama K, et al. Among authors: yamaguchi m. Rinsho Ketsueki. 2022;63(7):764-769. doi: 10.11406/rinketsu.63.764. Rinsho Ketsueki. 2022. PMID: 35922945 Japanese.

5

Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignancies.

Nakamura T, Oya S, Ozawa H, Maehiro Y, Muta S, Umeda M, Takaki Y, Fukuyama T, Yamasaki Y, Yamaguchi M, Aoyama K, Mouri F, Naito Y, Nagafuji K. Nakamura T, et al. Among authors: yamaguchi m. Int J Hematol. 2024 Apr;119(4):426-431. doi: 10.1007/s12185-024-03718-y. Epub 2024 Feb 16. Int J Hematol. 2024. PMID: 38363480

6

[Successful induction therapy for acute myeloid leukemia under management with extracorporeal membrane oxygenation].

Takaki Y, Yanai T, Shibata T, Honma T, Otsuka M, Yamasaki Y, Oya S, Nakamura T, Maehiro Y, Yamaguchi M, Aoyama K, Mouri F, Fukumoto Y, Nagafuji K. Takaki Y, et al. Among authors: yamaguchi m. Rinsho Ketsueki. 2024;65(5):330-334. doi: 10.11406/rinketsu.65.330. Rinsho Ketsueki. 2024. PMID: 38825509 Japanese.

7

CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs12459419 in gemtuzumab ozogamicin-mediated cytotoxicity.

Oya S, Ozawa H, Nakamura T, Mori A, Ochi S, Maehiro Y, Umeda M, Takaki Y, Fukuyama T, Yamasaki Y, Yamaguchi M, Aoyama K, Mouri F, Nagafuji K. Oya S, et al. Among authors: yamaguchi m. Int J Hematol. 2024 Aug;120(2):194-202. doi: 10.1007/s12185-024-03803-2. Epub 2024 Jun 10. Int J Hematol. 2024. PMID: 38853211

8

[Interleukin-6-producing paraganglioma mimicking multicentric Castleman disease].

Oya S, Yamasaki Y, Nakamura T, Morishige S, Yamaguchi M, Aoyama K, Seki R, Mouri H, Osaki K, Naito Y, Oshima K, Nagafuji K. Oya S, et al. Among authors: yamaguchi m. Rinsho Ketsueki. 2020;61(11):1605-1610. doi: 10.11406/rinketsu.61.1605. Rinsho Ketsueki. 2020. PMID: 33298654 Japanese.

9

[Use of pegylated granulocyte colony-stimulating factor in dose-adjusted EPOCH-R therapy].

Mouri F, Yamasaki Y, Ohya S, Nakamura T, Morishige S, Yamaguchi M, Aoyama K, Seki R, Osaki K, Nagafuji K. Mouri F, et al. Among authors: yamaguchi m. Rinsho Ketsueki. 2021;62(1):7-13. doi: 10.11406/rinketsu.62.7. Rinsho Ketsueki. 2021. PMID: 33551430 Japanese.

10

A case of lymphomatoid granulomatosis with central nervous system involvement successfully treated with IFNα.

Yamasaki Y, Morishige S, Komaki S, Furuta T, Koga H, Oya S, Nakamura T, Yamaguchi M, Aoyama K, Mouri F, Osaki K, Nakama T, Ohshima K, Morioka M, Nagafuji K. Yamasaki Y, et al. Among authors: yamaguchi m. Int J Hematol. 2021 Oct;114(4):502-508. doi: 10.1007/s12185-021-03178-8. Epub 2021 Jun 22. Int J Hematol. 2021. PMID: 34159518

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,046 results

Search Page

Filters